If you pursue a career in excellence science while improving patients’ health, then IDIBELL is your place.
The Bellvitge Institute of Biomedical Research (IDIBELL) is one of the most dynamic health research centers in Barcelona, Spain. Striving to attain significant improvements in human health, it boasts more than 800 researchers in translational, clinical, and epidemiological research. The research carried out by IDIBELL is structured in four areas: cancer, neuroscience, translational medicine, and regenerative medicine.
We are currently looking for Postdoctoral researchers interested in applying for a Marie Skłodowska-Curie Actions Fellowship (MSCA-IF). The scheme offers a 2-years contract for postdocs who are currently based abroad (or have been until recently based abroad). Not only the post-doctoral contract features offer a very attractive compensation package, but also, being a recipient of an MSCA-IF is a very remarkable career accomplishment.
Please check our current offers and apply for the one that is the most suitable for your profile!
In case you are selected, you will receive the necessary support in order to prepare a highly competitive proposal, including:
-an informative webseminar about how to prepare an MSCA-IF proposal, dedicated to IDIBELL’s candidates
-revision of the proposal by both our Preaward office and external scientific experts
The following research groups are still seeking candidates:
- Gene regulation of cell identity – Dr. PLASS
- Hematopoietic stem cell biology and leukemogenesis – Dr. GIORGETTI
- Stem Cell Aging – Dr. FLORIAN
- Stem Cell Potency Group – Dr. RAYA
IDIBELL has a longstanding track record in the participation in and successful coordination of European projects, with more than 40 FP7 and H2020 projects, including 18 Marie Skłodowska-Curie Actions (MSCA), 7 MSCA-ITN and 9 MSCA-IF
Do you want to know more about IDIBELL? http://www.idibell.cat